UID6144818
ÔĶÁȨÏÞ1
רҵ·Ö
¹±Ï×·Ö
°®Ò½±Ò
ÏÊ»¨
×¢²áʱ¼ä2017-4-19
|
¿ÉÄܵĻúÖÆ£ºÓÐÑо¿·¢ÏÖÔ¼Èý·ÖÖ®Ò»µÄITP»¼Õß´æÔÚ¿¹Á×Ö¬¿¹Ìå[1]¡¢ITP»¼Õß´æÔÚןü¸ßˮƽµÄѪС°åÔ´ÐÔ΢¿ÅÁ£[2]¡¢¼°¿¹Ìå°ü±»µÄѪС°åÄÜ´Ù½ø²¹Ì弤»î[3]£¬ÁíÍâITP»¼ÕßѪС°å±¾Éí¸üÄêÇá¡¢»îÐÔ¸ü¸ß£¬ÖÎÁƺóѪС°åÊýÁ¿ÉýµÃ¹ý¿ìµÈÒ²ÊÇ¿ÉÄܵÄÔÒò¡£ËùÒÔITPÖÎÁƲ»Ó¦ÊÔͼ½«PLT¼ÆÊýÉýÖÁÕý³£Ë®Æ½£¬3ÍòÒÔÉϼ´¿É£¬³¬¹ý5Íòʱ¶ÔͬʱºÏ²¢ÆäËûѪ˨·çÏյĻ¼ÕßÒª¿¼ÂÇ¿¹Äý´ëÊ©¡£ 1. Diz-Kucukkaya R, Hacehanefioglu A, Yenerel M et al. Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study. Blood. 2001;98:1760-1764. 2. Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med. 1992;119:334-345. 3. Peerschke EI, Yin W, Ghebrehiwet B. Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol. 2010;47:2170-2175. |
|